4
Changes in Ownership
Oric Pharmaceuticals, Inc. Filed Acc 0001415889-25-016386
Chief Financial Officer sold 2,900 shares at an average $10.01 ($29,021)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Piscitelli Dominic Chief Financial Officer | 2025-06-06 | Sale 10b5-1 | −2,600 | $10.01 | $26,021 | 104,164 | D |
| Piscitelli Dominic Chief Financial Officer | 2025-06-09 | Sale 10b5-1 | −300 | $10.00 | $3,000 | 103,864 | D |
| Open-market sales · 2,900 sh · avg $10.01 · $29,021 | |||||||
Loading xslF345X05/form4-06102025_120617.xml…